Lilly beats Novo in weight loss; Apogee plots Dupixent challenge; Biosecure compromise coming?; and morenews2024-12-07T11:00:26+00:00December 7th, 2024|Endpoints News|
Trump announces picks for FDA, CDC; Novartis seeks bolt-on deals, raises guidance; RFK Jr., Elon Musk may find banning ads difficult; and morenews2024-11-23T11:00:34+00:00November 23rd, 2024|Endpoints News|
Trump picks RFK Jr. for HHS; AbbVie’s psych implosion; Merck tries staving off Summit; and morenews2024-11-16T11:00:06+00:00November 16th, 2024|Endpoints News|
How Trump, RFK Jr. could influence biopharma; Viking presents weight loss data; Are MASH drugs getting boxed out by GLP-1s?; and morenews2024-11-09T11:00:54+00:00November 9th, 2024|Endpoints News|
How RFK Jr. might influence the FDA; Pharma’s Q3 highlights; AbbVie’s latest neuro buyout; and morenews2024-11-02T10:00:54+00:00November 2nd, 2024|Endpoints News|
